Both in Blank Checks

New Providence Acquisition Corp. III Units vs Drugs Made In America Acquisition Corp. Units

Over the past year NPACU returned +1.2% and DMAAU returned +4.2%; their daily moves had a correlation of 0.18.

NPACU +1.2% DMAAU +4.2%Growth of $1, one year, split-adjusted
MetricNPACUDMAAU
Price$10.51$10.99
Market cap$283.3M$224.2M
Today+0.10%+1.85%
1 month−0.8%—
6 months——
Year to date—+4.8%
1 year——
Revenue growth (YoY)——
Gross margin——
Net margin——
P/E (TTM)34.5×—
Price / sales——
Net cash$63.8K-$329.7K
Dividend yield——
Volatility (60d)7.0%—
Short % of float——
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).

NPACU vs DMAAU: New Providence Acquisition Corp. III Units vs Drugs Made In America Acquisition Corp. Units Stock Comparison | Gainbot